NCT05059626View on ClinicalTrials.gov

Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee

PHASE4RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Endometriosis
Interventions
DRUG

simvastatin 10mg

Simvastation acts as a systemic LOX inhibitor.

DRUG

Bazedoxifene 20/Estrogens,Con 0.45Mg Tb

Duavee is a selective estrogen receptor modulator.

Trial Locations (1)

06519

RECRUITING

The John B. Pierce Laboratory, New Haven

All Listed Sponsors
collaborator

The John B. Pierce Laboratory

OTHER

lead

Penn State University

OTHER